2Luxembourg B,Bauersachs R.Malignancy and thrombosis;a double-sided clinical relationship[J].Vasa,2005,34(4):225-234. 被引量：1
3Uaprasert N,Voorhees PM,Mackman N,et al.Venous thromboembolism in multiple myeloma.Current perspectives in pathogenesis[J].Eur J Cancer,2010,46(16):1790-1799. 被引量：1
4Prandoin P,Falanga A,Piccioli A.Cancer and venous thromboembolism[J].Lancet Oncol,2005,6(6):401. 被引量：1
5Lyman GH,Khorana AA,Falanga A,et al.American Society of Clinical Oncology guideline:recommendations for venous thromboebolism prophylaxis and treatment in patients with cancer[J].J Clin Oncol,2007,25(34):5490. 被引量：1
8Samama MM. An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius Study [ J ]. Arch Intern Med, 2000, 160 (22) : 3415 - 3420. 被引量：1
9Sorensen HT, Mellemkjaer L, Olsen JH, et al. Prognosis of cancers associated with venous thromboembolism [ J ]. N Engl J Med,2000,343 (25) : 1846 - 1850. 被引量：1
10Nishiok J, Goodin S. Low molecular weight heparin in cancer associated thrombosis : treatment, secondary prevention, and survival [ J ]. J Oncol Pharm Pract,2007, 13(2) :85 -97. 被引量：1
